Genetic association analysis of N-methyl-D-aspartate receptor subunit gene GRIN2B and clinical response to clozapine (Q46913948)

26 December 2017

title

Genetic association analysis of N-methyl-D-aspartate receptor subunit gene GRIN2B and clinical response to clozapine (English)

1 reference

26 December 2017

author

Jo Knight

6

1 reference

26 December 2017

Gary Remington

7

object named as

Gary Remington

1 reference

26 December 2017

Jeffrey Lieberman

3

object named as

Jeffrey A Lieberman

1 reference

26 December 2017

Herbert Y. Meltzer

5

0 references

Steven G. Potkin

4

0 references

James L. Kennedy

9

0 references

Daniel J. Müller

8

object named as

Daniel J Müller

1 reference

26 December 2017

author name string

Danielle L Taylor

1

1 reference

26 December 2017

Arun K Tiwari

2

1 reference

26 December 2017

publication date

15 February 2016

1 reference

26 December 2017

published in

Human Psychopharmacology

1 reference

26 December 2017

volume

31

1 reference

26 December 2017

issue

2

1 reference

26 December 2017

page(s)

121-134

1 reference

26 December 2017

Is schizoaffective disorder a distinct categorical diagnosis? A critical review of the literature

cites work

1 reference

Association between the NMDA glutamate receptor GRIN2B gene and obsessive-compulsive disorder

21 January 2018

1 reference

Typical and atypical antipsychotic occupancy of D2 and S2 receptors: an autoradiographic analysis in rat brain.

21 January 2018

1 reference

21 January 2018

2 references

21 January 2018

7 January 2021

Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction.

1 reference

Haploview: analysis and visualization of LD and haplotype maps

21 January 2018

1 reference

Clozapine disposition covaries with CYP1A2 activity determined by a caffeine test

21 January 2018

1 reference

Refractory schizophrenia: a neglected clinical problem

21 January 2018

1 reference

Serologic evidence of prenatal influenza in the etiology of schizophrenia

21 January 2018

1 reference

Maternal infections and subsequent psychosis among offspring.

21 January 2018

1 reference

Influence of polymorphisms in genes SLC1A1, GRIN2B, and GRIK2 on clozapine-induced obsessive-compulsive symptoms

21 January 2018

1 reference

Factors associated with noncompliance with psychiatric outpatient visits.

21 January 2018

1 reference

Association analysis of the genetic variants of the N-methyl D-aspartate receptor subunit 2b (NR2b) and treatment-refractory schizophrenia in the Chinese

21 January 2018

1 reference

Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors

21 January 2018

1 reference

Actions of clozapine and haloperidol on the extracellular levels of excitatory amino acids in the prefrontal cortex and striatum of conscious rats.

21 January 2018

1 reference

A meta-analysis of the efficacy of second-generation antipsychotics

21 January 2018

1 reference

Variations in the NMDA receptor subunit 2B gene (GRIN2B) and schizophrenia: a case-control study

21 January 2018

1 reference

Association of the glutamate receptor subunit gene GRIN2B with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data

21 January 2018

1 reference

21 January 2018

Refractory schizophrenia

1 reference

Remission in early psychosis: Rates, predictors, and clinical and functional outcome correlates.

21 January 2018

1 reference

Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes

21 January 2018

1 reference

New models of collaboration in genome-wide association studies: the Genetic Association Information Network

21 January 2018

1 reference

Sample size requirements for matched case-control studies of gene-environment interaction

21 January 2018

1 reference

The participation of cytochrome P450 3A4 in clozapine biotransformation is detected in people with schizophrenia by high-throughput in vivo phenotyping

21 January 2018

1 reference

Effect of chronic clozapine administration on [3H]MK801-binding sites in the rat brain: a side-preference action in cortical areas.

21 January 2018

1 reference

Duration of untreated psychosis and time to treatment response for delusions and hallucinations

21 January 2018

1 reference

Effect of caffeine on clozapine pharmacokinetics in healthy volunteers

21 January 2018

1 reference

Mendelian proportions in a mixed population

21 January 2018

1 reference

Glutamatergic neurotransmission modulation and the mechanisms of antipsychotic atypicality

21 January 2018

1 reference

Double-blind, placebo-controlled, crossover trial of glycine adjuvant therapy for treatment-resistant schizophrenia.

21 January 2018

1 reference

The glycine binding site of the N-methyl-D-aspartate receptor subunit NR1: identification of novel determinants of co-agonist potentiation in the extracellular M3-M4 loop region.

21 January 2018

1 reference

Association analysis for NMDA receptor subunit 2B (GRIN2B) genetic variants and psychopathology and clozapine response in schizophrenia

21 January 2018

1 reference

ACS chemical neuroscience molecule spotlight on RG1678.

21 January 2018

1 reference

Detection of genotyping errors by Hardy-Weinberg equilibrium testing.

21 January 2018

1 reference

Familial differential treatment response in schizophrenia--lessons from a case of three affected siblings.

21 January 2018

1 reference

Gene-gene interaction analyses between NMDA receptor subunit and dopamine receptor gene variants and clozapine response.

21 January 2018

1 reference

Recent advances in the phencyclidine model of schizophrenia

21 January 2018

1 reference

Network-assisted investigation of combined causal signals from genome-wide association studies in schizophrenia

21 January 2018

1 reference

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

21 January 2018

1 reference

Antipsychotic drugs reverse the disruption in prefrontal cortex function produced by NMDA receptor blockade with phencyclidine.

21 January 2018

1 reference

The positive and negative syndrome scale (PANSS) for schizophrenia

21 January 2018

1 reference

The social and economic burden of treatment-resistant schizophrenia: a systematic literature review

21 January 2018

1 reference

Pharmacogenetics in schizophrenia: a review of clozapine studies

21 January 2018

1 reference

Modulation of neuronal migration by NMDA receptors.

21 January 2018

1 reference

Childhood-onset schizophrenia. A double-blind clozapine-haloperidol comparison

21 January 2018

1 reference

Mutational analysis of the glycine-binding site of the NMDA receptor: structural similarity with bacterial amino acid-binding proteins

21 January 2018

1 reference

A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies

21 January 2018

1 reference

Effects of ketamine in normal and schizophrenic volunteers

21 January 2018

1 reference

Molecular determinants of agonist discrimination by NMDA receptor subunits: analysis of the glutamate binding site on the NR2B subunit

21 January 2018

1 reference

Clinical effects of clozapine in chronic schizophrenia: response to treatment and predictors of outcome

21 January 2018

1 reference

Reversal of phencyclidine-induced prepulse inhibition deficits by clozapine in monkeys

21 January 2018

1 reference

Controlling Population Structure in Human Genetic Association Studies with Samples of Unrelated Individuals

21 January 2018

1 reference

Clozapine blunts N-methyl-D-aspartate antagonist-induced psychosis: a study with ketamine.

21 January 2018

1 reference

Mapping of the human NMDAR2B receptor subunit gene (GRIN2B) to chromosome 12p12

21 January 2018

1 reference

Differential roles of NR2A and NR2B-containing NMDA receptors in cortical long-term potentiation and long-term depression.

21 January 2018

1 reference

Olanzapine: concordant response in monozygotic twins with schizophrenia

21 January 2018

1 reference

Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones

21 January 2018

1 reference

Validating specific psychopathology scales in older outpatients with schizophrenia

21 January 2018

1 reference

A selective review of recent North American long-term followup studies of schizophrenia

21 January 2018

1 reference

Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: impact on risk-benefit assessment

21 January 2018

1 reference

Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs

21 January 2018

1 reference

Toxoplasma gondii as a risk factor for early-onset schizophrenia: analysis of filter paper blood samples obtained at birth

21 January 2018

1 reference

Clozapine is a partial agonist at cloned, human serotonin 5-HT1A receptors.

21 January 2018

1 reference

Differential effects of atypical and typical antipsychotic drugs on N-methyl-D-aspartate- and electrically evoked responses in the pyramidal cells of the rat medial prefrontal cortex

21 January 2018

1 reference

Enhancement of immobility in a forced swimming test by subacute or repeated treatment with phencyclidine: a new model of schizophrenia

21 January 2018

1 reference

Magnesium gates glutamate-activated channels in mouse central neurones

21 January 2018

1 reference

A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other

21 January 2018

1 reference

Chronic haloperidol and clozapine administration increases the number of cortical NMDA receptors in rats.

21 January 2018

1 reference

Refinement of phenomenological classification in clinical psychopharmacology research

21 January 2018

1 reference

Clozapine, norclozapine plasma levels, their sum and ratio in 50 psychotic patients: influence of patient-related variables

21 January 2018

1 reference

Association between the GRM7 rs3792452 polymorphism and attention deficit hyperacitiveity disorder in a Korean sample

21 January 2018

1 reference

Tracing sub-structure in the European American population with PCA-informative markers

21 January 2018

1 reference

Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial

21 January 2018

1 reference

Glutamate acting on NMDA receptors stimulates neurite outgrowth from cerebellar granule cells.

21 January 2018

1 reference

Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis

21 January 2018

1 reference

Clinical and biologic response to clozapine in patients with schizophrenia. Crossover comparison with fluphenazine

21 January 2018

1 reference

First in vivo evidence of an NMDA receptor deficit in medication-free schizophrenic patients

21 January 2018

1 reference

Selective GlyT1 inhibitors: discovery of [4-(3-fluoro-5-trifluoromethylpyridin-2-yl)piperazin-1-yl][5-methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methylethoxy)phenyl]methanone (RG1678), a promising novel medicine to treat schizophrenia

21 January 2018

1 reference

Discerning the ancestry of European Americans in genetic association studies

21 January 2018

1 reference

PLINK: a tool set for whole-genome association and population-based linkage analyses

21 January 2018

1 reference

Clozapine functions through the prefrontal cortex serotonin 1A receptor to heighten neuronal activity via calmodulin kinase II-NMDA receptor interactions.

21 January 2018

1 reference

The relevance of "missing heritability " in pharmacogenomics

21 January 2018

1 reference

Gene-gene-environment interactions between drugs, transporters, receptors, and metabolizing enzymes: Statins, SLCO1B1, and CYP3A4 as an example

21 January 2018

1 reference

From genotypes to genes: doubling the sample size

21 January 2018

1 reference

NMDA receptors amplify calcium influx into dendritic spines during associative pre- and postsynaptic activation

21 January 2018

1 reference

Biological insights from 108 schizophrenia-associated genetic loci

21 January 2018

1 reference

Effects of long-term antipsychotic treatment on NMDA receptor binding and gene expression of subunits

21 January 2018

1 reference

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

21 January 2018

1 reference

Antipsychotic Drugs: Direct Correlation Between Clinical Potency and Presynaptic Action on Dopamine Neurons

21 January 2018

1 reference

Plasticity, hippocampal place cells, and cognitive maps

21 January 2018

1 reference

Current perspectives in the treatment of resistant schizophrenia

21 January 2018

1 reference

Rates of adult schizophrenia following prenatal exposure to the Chinese famine of 1959-1961.

21 January 2018

1 reference

Repeated antipsychotic treatment progressively potentiates inhibition on phencyclidine-induced hyperlocomotion, but attenuates inhibition on amphetamine-induced hyperlocomotion: relevance to animal models of antipsychotic drugs

21 January 2018

1 reference

Schizophrenia after prenatal exposure to the Dutch Hunger Winter of 1944-1945.

21 January 2018

1 reference

No association of three GRIN2B polymorphisms with lithium response in bipolar patients.

21 January 2018

1 reference

Comparative efficacy of antipsychotics in the treatment of schizophrenia: a critical assessment

21 January 2018

1 reference

Clozapine-induced weight gain: a study in monozygotic twins and same-sex sib pairs

21 January 2018

1 reference

Activation of NMDA receptors promotes dendritic spine development through MMP-mediated ICAM-5 cleavage.

21 January 2018

1 reference

Characterization of protein kinase A and protein kinase C phosphorylation of the N-methyl-D-aspartate receptor NR1 subunit using phosphorylation site-specific antibodies.

21 January 2018

1 reference

Mathematical properties of the r2 measure of linkage disequilibrium

21 January 2018

1 reference

Rational inferences about departures from Hardy-Weinberg equilibrium

21 January 2018

1 reference

Rationale for the study of early intervention

21 January 2018

1 reference

SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies

21 January 2018

1 reference

Family based association of GRIN2A and GRIN2B with Korean autism spectrum disorders.

21 January 2018

1 reference

A study of N-methyl-D-aspartate receptor gene (GRIN2B) variants as predictors of treatment-resistant major depression

21 January 2018

1 reference

Neural basis of the potentiated inhibition of repeated haloperidol and clozapine treatment on the phencyclidine-induced hyperlocomotion

21 January 2018

1 reference

The mystery of missing heritability: Genetic interactions create phantom heritability

21 January 2018

1 reference

Identification of amino acid residues of the NR2A subunit that control glutamate potency in recombinant NR1/NR2A NMDA receptors

21 January 2018

1 reference

7 January 2021

Dopamine receptors and average clinical doses

1 reference

7 January 2021

Clozapine treatment increases serum glutamate and aspartate compared to conventional neuroleptics

1 reference

7 January 2021

Regulation of cortical and subcortical glutamate receptor subunit expression by antipsychotic drugs

1 reference

7 January 2021

Effects of neuroleptics on phencyclidine (PCP)-induced locomotor stimulation in mice

1 reference

7 January 2021

Ten-year outcome: patients with schizoaffective disorders, schizophrenia, affective disorders and mood-incongruent psychotic symptoms

1 reference

7 January 2021

Clozapine-induced concordant agranulocytosis in monozygotic twins

1 reference

7 January 2021

EM colocalization of AMPA and NMDA receptor subunits at synapses in rat cerebral cortex

1 reference

7 January 2021

Effects of MK-801 on clozapine-induced potentiation of excitatory synaptic responses in the perforant path-dentate gyrus pathway in chronically prepared rabbits

1 reference

7 January 2021

Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature

1 reference

7 January 2021

Symptom rating scales and outcome in schizophrenia.

1 reference

7 January 2021

Clozapine serum concentrations are lower in smoking than in non-smoking schizophrenic patients

1 reference

7 January 2021

A prospective study of stressful life events and schizophrenic relapse

1 reference

7 January 2021

Monozygotic twins concordant for response to clozapine

1 reference

7 January 2021

Calcium influx via the NMDA receptor induces immediate early gene transcription by a MAP kinase/ERK-dependent mechanism.

1 reference

7 January 2021

Differential effects of chronic antipsychotic drug treatment on extracellular glutamate and dopamine concentrations.

1 reference

7 January 2021

Identifiers

DOI

10.1002/HUP.2519

1 reference

26 December 2017

PubMed ID

26876050

1 reference

26 December 2017